Summary:
Click image to enlarge
About the study If you decide to join and are eligible, the ENVISION study will last for up to approximately 130 weeks (2 and a half years), including an 8-week screening period (to determine your eligibility), 104-week (2-year) treatment period and an 18-week follow-up period. During the treatment period, all participants will receive either the study drug or a placebo (a substance that looks the same as the study drug but contains no active ingredients). If you decide to join the ENVISION study, you will need to visit a study clinic approximately 40 times so that we can monitor your general health and condition with health assessments such as blood tests, brain MRI scans, neurological examinations, urine tests and vital signs. You will also have up to eight follow-up phone calls.
We are looking for people, who, among other things:
Qualified Participants May Receive:
Study treatment and health assessments will be provided to you at no cost, and you may be reimbursed for travel expenses. You do not need to have health insurance to participate.